In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency.
Tilly-Kiesi M, Packard CJ, Kahri J, Ehnholm C, Shepherd J, Taskinen MR.
Tilly-Kiesi M, et al. Among authors: kahri j.
Atherosclerosis. 1997 Feb 10;128(2):213-22. doi: 10.1016/s0021-9150(96)05992-8.
Atherosclerosis. 1997.
PMID: 9050778
Previously we have identified a Finnish family with an apo A-I variant (Lys107-->0) associated with reduced plasma HDL cholesterol level and decreased lipoprotein (Lp)(AI w AII) concentration compared to unaffected family members. To determine the in vivo metabolism of …
Previously we have identified a Finnish family with an apo A-I variant (Lys107-->0) associated with reduced plasma HDL cholesterol level …